Clinical Trials Browser

Phase 1 × S-1,2-dichlorovinyl-N-acetylcysteine × Clear all

NCT05277753 2022-03-15

NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05262673 2022-03-08

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

Phase 1 Unknown

Burkitt Lymphoma